Evidence map›Paper›PMID 37641866›Full record

ArticleThe Journal of international medical research2023

Efficacy of gefapixant, a P2X

Yoshihisa Ishiura, Shosaku Nomura, Yuka Ishii, Kai Imai, Yusuke Sawai, Takeshi Tamaki, Toshiki Shimizu, Naoyuki Miyashita, Tomoki Ito

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yoshihisa IshiuraFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.ORCID 0000-0003-0320-1193
Shosaku NomuraFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Yuka IshiiFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Kai ImaiFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Yusuke SawaiFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Takeshi TamakiFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Toshiki ShimizuFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Naoyuki MiyashitaFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Tomoki ItoFirst Department of Internal Medicine, Kansai Medical University, Osaka, Japan.
Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cough is a frequent symptom accompanied by lung cancer. More potent antitussive treatment for this complex and distressing symptom is required, but anti-cancer chemotherapy cannot fully manage the cough. Inhibition of vagal nerves might control coughing in patients with troublesome lung cancer-related cough and P2X

Indexed as

Antitussive AgentsLung NeoplasmsBenzenesulfonamidesCoughFemaleHumansPyrimidinesSulfonamidesAntitussive AgentsBenzenesulfonamidesGefapixantPyrimidinesSulfonamideschronic coughGefapixantLeicester Cough Questionnairelung cancerlung cancer-related coughP2X3

Identifiers

PMID37641866
PMCPMC10467400
OpenAlexW4386257895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.